(Q46038653)

18 December 2017

title

Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. (English)

1 reference

18 December 2017

1 reference

1 reference

1 reference

Ramsey C Cheung

1

1 reference

18 December 2017

Sue Currie

2

1 reference

18 December 2017

Hui Shen

3

1 reference

18 December 2017

Samuel B Ho

4

1 reference

18 December 2017

Edmund J Bini

5

1 reference

18 December 2017

Bhupinderjit S Anand

6

1 reference

18 December 2017

Norbert Bräu

7

1 reference

18 December 2017

Teresa L Wright

8

1 reference

18 December 2017

VA HCV-001 Study Group

9

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

18 December 2017

The American Journal of Gastroenterology

published in

1 reference

18 December 2017

volume

100

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

2186-2193

1 reference

18 December 2017

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Hepatitis C infection in African Americans: its natural history and histological progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Racial differences in liver inflammation and fibrosis related to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Hepatitis C in a Los Angeles public hepatitis clinic: demographic and biochemical differences associated with race-ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Differences in treatment outcome for hepatitis C among ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Epidemiology of hepatitis C virus infection in American veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Limited success of HCV antiviral therapy in United States veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

Racial differences in response rates to consensus interferon in HCV infected patients naive to previous therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00240.X

10.1111/J.1572-0241.2005.00240.X

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017